Association between serum hormone levels in early pregnancy and risk of hypertensive diseases of pregnancy in women undergoing assisted reproduction
Journal of Assisted Reproduction and Genetics · 2024
DOI: 10.1007/s10815-024-03212-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2024. Verfasst von Rachel A Martel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA. rmartel23@gmail.com. Hauptthemen laut MEDLINE: Progesterone, Reproductive Techniques, Assisted, Embryo Transfer, Chorionic Gonadotropin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
We examined the association between progesterone (P4), estradiol (E2), and human chorionic gonadotropin (hCG) levels in early pregnancy and the development of hypertensive diseases of pregnancy among women undergoing assisted reproduction.
Methods
Retrospective study including patients who underwent frozen embryo transfer (FET), ovarian stimulation (OS), or unassisted conception (UC) and had a live singleton birth. The primary outcome was the development of hypertensive diseases of pregnancy (gestational hypertension, preeclampsia, HELLP, or eclampsia). Secondary outcomes were the development of fetal intrauterine growth restriction (IUGR), gestational diabetes mellitus, birth weight, and pre-term birth. Hormone levels and the development of the outcomes were correlated.
Results
A total of 681 patients were included; 189 had FET, 193 had OS, and 299 had UC. Patients undergoing FET or OS were not more likely to develop hypertensive diseases of pregnancy compared with UC patients. While median levels of E2 and P4 were significantly different between P-FET and NC-FET patients (E2: 252 vs 317 pg/mL, P4: 64 vs 29 ng/mL, respectively; both p < 0.01), rates of hypertensive diseases of pregnancy did not significantly differ between those two groups. In the multivariate analyses, P4, E2, and hCG were not associated with the development of hypertensive diseases of pregnancy, but progesterone levels were significantly higher among those with IUGR. This remained consistent when the analysis was limited to FET patients.
Conclusion
P4, E2, and hCG levels did not correlate with the development of hypertensive diseases of pregnancy but elevated progesterone levels did correlate with the development of IUGR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA. rmartel23@gmail.com.
- Department of Obstetrics and Gynecology, UCLA David Geffen School of Medicine, 10833 Le Conte Avenue, 27-139 CHS, Los Angeles, CA, 90095-1740, USA. rmartel23@gmail.com.
- UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
- Department of Obstetrics and Gynecology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
- Department of Urology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Zitieren
APA
Martel, R. A., Lee, V., Armstrong, A., Demirjian, M., Kwan, L., & Al-Safi, Z. A. (2024). Association between serum hormone levels in early pregnancy and risk of hypertensive diseases of pregnancy in women undergoing assisted reproduction. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-024-03212-8
Vancouver
Martel RA, Lee V, Armstrong A, Demirjian M, Kwan L, Al-Safi ZA. Association between serum hormone levels in early pregnancy and risk of hypertensive diseases of pregnancy in women undergoing assisted reproduction. Journal of Assisted Reproduction and Genetics. 2024. doi:10.1007/s10815-024-03212-8
BibTeX
@article{Martel2024,
author = {Martel, Rachel A and Lee, Victoria and Armstrong, Abigail and Demirjian, Maral and Kwan, Lorna and Al-Safi, Zain A},
title = {Association between serum hormone levels in early pregnancy and risk of hypertensive diseases of pregnancy in women undergoing assisted reproduction},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2024},
doi = {10.1007/s10815-024-03212-8}
}
EUVIMED